Aurobindo Pharma Ltd is pleased to announce that Medicines Control Council (MCC) South Africa has granted 23 registrations to manufacture and market products in South Africa.
The products approved are as follows:
|
Product Names |
Strength |
Dosage Form |
Generic Name |
| Bavir |
300 mg |
Tablets |
Abacavir Sulfate |
| Deladex; Soniren; Segiref |
200, 250, 400 mg |
DR Capsules |
Didanosine |
| Apafar; Stabinez; Zenvir |
600 mg |
Tablets |
Efavirenz |
| Colazid |
150mg+300mg |
Tablets |
Lamivudine + Zidovudine |
| Bindolam |
10 mg/ml |
Oral Solution |
Lamivudine |
| Bindopin |
200 mg |
Tablets |
Nevirapine |
| Auro-Ribavirin; Dorik |
200 mg |
Tablets |
Ribavirin |
| Cylor; Vireno; Zefin |
300 mg |
Tablets |
Tenofovir Disoproxil Fumarate |
| Zynovir |
100, 250 mg |
Capsules |
Zidovudine |
| Emtricitabine/Tenofovir Auro; Tyricten |
200+300 mg |
Tablets |
Emtricitabine +Tenofovir Disoproxil Fumarate |
| Auro-Meloxicam, Flamaryx |
7.5, 15 mg |
Tablets |
Meloxicam |
| Nysivir |
2, 4 g |
Oral solution |
Didanosine |
| Zynovir |
50mg/5 ml |
Oral Solution |
Zidovudine |
| Bindopin |
50mg/5 ml |
Oral Suspension |
Nevirapine |
Aurobindo now has a total of 48 products representing 91 registrations approved by the MCC.